Cambodia's Hun Sen says Molnupiravir is free for frontline worker as health ministry reports another 306 Omicton cases


Frontline medical workers vaccinate children aged 3-4 against Covid-19 at Pochentong Referral Hospital in Phnom Penh’s Por Sen Chey district in late February. - Phnom Penh Post/ANN

PHNOM PENH, March 7 (Phnom Penh Post/ANN): Cambodian Prime Minster Hun Sen has granted approval for healthcare institutions to provide Covid-19 antiviral medicine Molnupiravir at no cost to medical and frontline workers who have tested positive and are exhibiting mild symptoms that can be treated at home.

The move comes amid a large community spread of the Omicron coronavirus variant, which officials note has also affected frontline workers and impacted provision of healthcare services throughout the Kingdom.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Aseanplus News

No end to Cambodia pageant issue - Miss Planet Cambodia alleges that result of beauty event was ‘pre-planned’
Sze Fei-Izzuddin finish runners-up in World Tour Finals
Macao's fusion food: A mix of East and West with recipes passed down generations
Saudi-hosted UN talks end with no drought deal, say participants
Cambodia holds "Angkor Thanksgiving" event at famed Angkor park with thousands in attendance
Filipino woman on Indonesia death row recalls a stunning last minute reprieve and 'miracle' transfer
Cold Moon lights up the night sky in Singapore and beyond
South Korean opposition urges swift removal of impeached President Yoon
'We're home safe' - Five heroin traffickers return to Australia after almost 20 years in Indonesian prisons
'It is no longer free', but enough Paxlovid stock to treat Covid-19 in at-risk adults, says Singapore

Others Also Read